As part of the upgraded policy, the company’s customers will enjoy a range of unique and exclusive coverage for Ayalon’s health insurance, such as compensation for the discovery of one of 43 serious illnesses and complex medical events, including diseases that have not been addressed so far. And early detection of pre-prostate and breast cancer and compensation for therapeutic coronary catheterization.
In addition, the policy guarantees payment of compensation to the beneficiary in the event of the death of the insured, after 14 days from the date of discovery of the disease and everything in the premium varies according to the age of the insured.
In recent years, Ayalon has more than doubled its market share in the healthcare industry and its sales volume in the collective and individual areas is growing by tens of percent every year. The company offers up-to-date and flexible health policies that include very broad coverage for non-basket medications, coverage for customized medications (up to NIS 600,000) that fills every two years and for genomic tests, free choice of surgeon and indemnification for non-arrangement physicians, surgeries in Israel and abroad and of course ambulatory medical services. Extremely broad, including coverage for the innovative Colonflag test, which predicts the risk of colon cancer without the need for an invasive test.
Dr. Nava Niv Serodio, Director of the Ayalon Health Department notes: “We make sure to upgrade and expand our health policies all the time in accordance with the development of medicine in the world and offer Ayalon customers – at no extra cost, up-to-date, customized medicine and in many cases, really life-saving. Ayalon health insurance is highly recognized throughout the industry Our relative advantages are for Ayalon’s insured and, of course, for our excellent agents. “